AI Governance & Risk Advisory
You’re deploying AI in a healthcare environment. The technology may be ready. But is your organisation prepared to effectively govern it, and to demonstrate that to regulators, partners, and patients?
What it is
While regulatory assessments help organisations understand how external policy environments may affect market access and deployment strategies, AI Governance & Risk Advisory focuses inward. It examines whether governance structures, accountability mechanisms, operational processes, and oversight functions have evolved at the same pace as AI adoption.
Many AI initiatives prioritise technical capability while underestimating questions of institutional readiness, decision ownership, escalation pathways, and long-term organisational risk. In practice, governance failures rarely emerge from the technology alone; they arise from the environments into which it is introduced.
HealthTechAsia’s AI Governance & Risk Advisory supports healthcare institutions, health AI companies, and digital health platforms across ASEAN and the Middle East in evaluating whether their governance frameworks are sufficiently robust before regulators, partners, investors, or incidents force the question.
What you get
- An assessment of AI-related risks and governance maturity
- Mapping of regulatory and policy implications across relevant markets
- A structured Regulatory Impact Assessment where applicable
- Practical frameworks for responsible AI deployment
- Policy advisory, implementation reviews, and stakeholder engagement
- Guidance on emerging global regulatory developments
Who this is for
Governments, healthcare institutions, international organisations, and businesses seeking to deploy AI responsibly while maintaining public trust, operational resilience, and regulatory preparedness.
To get started
Send a brief note to team@healthtechasia.co describing your organisation and the market or challenge you’re navigating. We’ll confirm scope and availability within two business days.